pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›calendar
  3. ›approval
approval
save

OMLYCLO (OMALIZUMAB-IGEC) — FDA approval

March 7, 2025omalizumab biosimilarupdated 5mo ago
community read0 votes

Sponsor: CELLTRION INC. Form: INJECTABLE. Route: INJECTION

view source ↗
Data sources
fda approvals
last refreshed 5mo ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

drug timeline · 1

  • approvalOMLYCLO (OMALIZUMAB-IGEC) — FDA approvalDec 1, 2025 · 307d ago

same company · ±60 days · 5

  • approvalOSENVELT: OSENVELT (DENOSUMAB-BMWO) — FDA approvalFeb 28, 2025
  • approvalYUFLYMA: YUFLYMA (ADALIMUMAB-AATY) — FDA approvalApr 7, 2025
  • approvalAVTOZMA: AVTOZMA (TOCILIZUMAB-ANOH) — FDA approvalJan 24, 2025
  • approvalSTEQEYMA: STEQEYMA (USTEKINUMAB-STBA) — FDA approvalApr 28, 2025
  • approvalSTEQEYMA: STEQEYMA (USTEKINUMAB-STBA) — FDA approvalApr 30, 2025

🐶 often sniffed alongside

top 6
  • drugomalizumab6 co-mentions · 4 sources
  • tagApproval4 co-mentions · 2 sources
  • drugOMLYCLO4 co-mentions · 2 sources
  • company$CAHCARDINAL HEALTH INC2 co-mentions · 2 sources
  • companyCelltrion Inc2 co-mentions · 2 sources
  • tagRecall2 co-mentions · 2 sources

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?